AAAAAA
Results: 1-25/71
Authors:
LUMMEN G
SPERLING H
BEX A
OTTO T
RUBBEN H
Citation: G. Lummen et al., MODERN CONCEPTS IN THE THERAPY OF URINARY-TRACT (KIDNEY, URETER, BLADDER AND PROSTATE) TUMORS, Pharmacological research, 38(3), 1998, pp. 151-164
Authors:
LUMMEN G
SPERLING H
LUBOLDT H
OTTO T
RUBBEN H
Citation: G. Lummen et al., PHASE-II TRIAL OF TITANOCENE DICHLORIDE IN ADVANCED RENAL-CELL CARCINOMA, Cancer chemotherapy and pharmacology, 42(5), 1998, pp. 415-417
Authors:
BEX A
RUBBEN H
Citation: A. Bex et H. Rubben, WHEN SHOULD BE BEGIN WITH ANDROGEN DEPRIV ATION, Der Urologe, 37(2), 1998, pp. 133-134
Authors:
BEX A
RUBBEN H
Citation: A. Bex et H. Rubben, THERAPY OF HORMONEREFRACTORY CANCER OF TH E PROSTATE, Der Urologe, 37(2), 1998, pp. 159-161
Authors:
RUBBEN H
Citation: H. Rubben, PRESELECTED BIOPSY FOR NORMAL-APPEARING MUCOSA OF SUPERFICIAL BLADDER-CARCINOMA - COMMENT, European urology, 34(5), 1998, pp. 409-410
Authors:
KREGE S
OTTO T
HINKE A
GOEPEL M
RUBBEN H
Citation: S. Krege et al., PROSPECTIVE RANDOMIZED MULTICENTER PHASE-II STUDY FOR ADVANCED BLADDER-CANCER - CISPLATIN PLUS METHOTREXATE + - FACTOR AF2/, The Journal of urology, 159(5), 1998, pp. 637-637
Authors:
BOHM M
KIRCH H
OTTO T
WIELAND I
RUBBEN H
Citation: M. Bohm et al., NEW PROGNOSTIC MARKER IN TRANSITIONAL-CELL CARCINOMA - DELETION AT THE DEL-27 TUMOR-SUPPRESSOR LOCUS ON 5P13-12 CORRELATES WITH TUMOR PROGRESSION, The Journal of urology, 159(5), 1998, pp. 1094-1094
Authors:
VIRCHOW S
ANSORGE N
RUBBEN H
SIFFERT G
SIFFERT W
Citation: S. Virchow et al., ENHANCED FMLP-STIMULATED CHEMOTAXIS IN HUMAN NEUTROPHILS FROM INDIVIDUALS CARRYING THE G-PROTEIN BETA-3 SUBUNIT-825 T-ALLELE, FEBS letters, 436(2), 1998, pp. 155-158
Authors:
STOHRER M
KRAMER G
GOEPEL M
LOCHNERERNST D
KRUSE D
RUBBEN H
Citation: M. Stohrer et al., BLADDER AUTOAUGMENTATION IN ADULT PATIENTS WITH NEUROGENIC VOIDING DYSFUNCTION, Spinal cord, 35(7), 1997, pp. 456-462
Authors:
LUMMEN G
SPERLING H
LUBOLDT H
OTTO T
RUBBEN H
Citation: G. Lummen et al., INTERFERON-ALPHA AND INTERFERON-GAMMA IN ADVANCED RENAL-CELL CARCINOMA - TREATMENT RESULTS, SURVIVAL, AND PROGNOSTIC FACTORS IN 81 PATIENTS, Onkologie, 20(6), 1997, pp. 466-471
Authors:
BRANDLE E
HAUTMANN R
ALKEN P
HESSE A
SCHAFER R
RICHTERREICHHELM M
SCHALKHAUSER K
RUBBEN H
MELCHIOR H
Citation: E. Brandle et al., URINARY CALCULUS - DIAGNOSTICS, Der Urologe, 36(6), 1997, pp. 579-581
Authors:
BRANDLE E
HAUTMANN R
ALKEN P
HESSE A
SCHAFER R
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
RUBBEN H
MELCHIOR H
Citation: E. Brandle et al., INDICATIONS FOR CALCULUS THERAPY, Der Urologe, 36(6), 1997, pp. 582-584
Authors:
BRANDLE E
HAUTMANN R
ALKEN P
HESSE A
SCHAFER R
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
RUBBEN H
MELCHIOR H
Citation: E. Brandle et al., TECHNIQUES OF INTERVENTIONAL AND SURGICAL CALCULUS THERAPY, Der Urologe, 36(6), 1997, pp. 585-587
Authors:
BRANDLE E
HAUTMANN R
ALKEN P
HESSE A
SCHAFER R
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
MELCHIOR H
RUBBEN H
STOCKAMP K
Citation: E. Brandle et al., METAPHYLAXIS OF URINARY CALCULUS DISEASE, Der Urologe, 36(6), 1997, pp. 588-593
Authors:
RUBBEN H
Citation: H. Rubben, DEVELOPMENT OF GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF UROLOGICAL DISORDERS, Der Urologe, 36(5), 1997, pp. 485-486
Authors:
HOFSTETTER A
BRUHL P
NABER KG
WEIDNER W
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
RUBBEN H
SCHABEL J
STOCKAMP K
Citation: A. Hofstetter et al., DIAGNOSIS OF INFECTIONS OF THE UROGENITALTRACT, Der Urologe, 36(5), 1997, pp. 487-489
Authors:
NABER G
BRUHL P
WEIDNER W
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
RUBBEN H
SCHABEL J
STOCKAMP K
Citation: G. Naber et al., TREATMENT OF URINARY-TRACT INFECTIONS, Der Urologe, 36(5), 1997, pp. 490-492
Authors:
BRUHL P
NABER K
WEIDNER W
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
RUBBEN H
SCHABEL J
STOCKAMP K
Citation: P. Bruhl et al., TREATMENT OF UROGENITAL TUBERCULOSIS, Der Urologe, 36(5), 1997, pp. 493-496
Authors:
HOFSTETTER A
WEIDNER W
BRUHL P
NABER KG
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
RUBBEN H
SCHABEL J
STOCKAMP K
Citation: A. Hofstetter et al., INFECTIONS OF ANDROLOGICAL SIGNIFICANCE, Der Urologe, 36(5), 1997, pp. 496-499
Authors:
WEIDNER W
WEISKE WH
WETTERAUER W
RICHTERREICHHELM M
SCHALKHAUSER K
HULAND H
LUDWIG G
RUBBEN H
STOCKAMP K
Citation: W. Weidner et al., DIAGNOSIS OF INFERTILITY, Der Urologe, 36(5), 1997, pp. 499-502
Authors:
SCHUBERT J
SCHABEL J
HULAND H
RICHTERREICHHELM M
SCHALKHAUSER K
JOCHAM D
RUBBEN H
THUROFF J
Citation: J. Schubert et al., DIAGNOSIS AND TREATMENT STANDARDS IN KIDNEY-TRANSPLANTATION - SUMMARYFOR THE INTERNET, Der Urologe, 36(5), 1997, pp. 502-503
Authors:
OTTO T
KREGE S
GOEPEL M
BASCHEK R
RUBBEN H
Citation: T. Otto et al., LONG-TERM RESULTS OF OPERATIVE THERAPY FO R METASTASIZED NONSEMINOMATOUS GERM-CELL TUMORS (NSGT) IN ADVANCED TUMOR STAGES, Der Urologe, 36(4), 1997, pp. 339-342
Authors:
LUMMEN G
SPERLING H
RUBBEN H
Citation: G. Lummen et al., BURKITTS-LYMPHOMA A RARE CAUSE FOR HYDRON EPHROSIS, Der Urologe, 36(3), 1997, pp. 239-242
Authors:
OTTO T
KREGE S
OTTO B
GOEPEL M
RUBBEN H
Citation: T. Otto et al., 2ND-LINE CHEMOTHERAPY WITH MITOMYCIN-C AN D 5-FLUOROURACIL IN THE TREATMENT OF REFRACTORY METASTATIC CANCER OF THE URINARY-BLADDER, Der Urologe, 36(3), 1997, pp. 243-247
LONG-TERM RESULTS OF WALLSTENT IMPLANTATI ON IN BENIGN PROSTATIC HYPERPLASIA AND IN HIGH-RISK GROUPS
Authors:
GOEPEL M
SENGE A
OTTO T
RUBBEN H
Citation: M. Goepel et al., LONG-TERM RESULTS OF WALLSTENT IMPLANTATI ON IN BENIGN PROSTATIC HYPERPLASIA AND IN HIGH-RISK GROUPS, Der Urologe, 36(2), 1997, pp. 151-156